News

Moderna, Inc. announced an agreement with the European Commission (EC) to amend their originally agreed contractual delivery schedules for the Moderna COVID-19 vaccine booster product…
Read More...

Myovant Sciences and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) accepted for review a supplemental New Drug Application (sNDA) for MYFEMBREE® (relugolix 40…
Read More...

Theolytics is a biotechnology company harnessing viruses to combat disease. The company has been awarded a Biomedical catalyst grant by Innovate UK to progress a novel therapy for…
Read More...

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle,…
Read More...

Cocrystal Pharma, Inc. announces a Non-Clinical Evaluation Agreement (NCEA) with the National Institute of Allergy and Infectious Diseases (NIAID) for exploratory preclinical studies to…
Read More...

Amneal Pharmaceuticals, Inc. announced the commercial launch of LYVISPAH, a baclofen oral granules (5, 10 and 20 mg) specialty product approved by the U.S. Food and Drug Administration…
Read More...

Astellas Pharma Inc. and GO Therapeutics, Inc. announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos") and GO have entered into a strategic research…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has approved a label extension for Evrysdi® (risdiplam) to include babies under two months old with spinal muscular…
Read More...

GSK plc announced that it has entered into a definitive agreement to acquire Affinivax, Inc. (Affinivax), a clinical-stage biopharmaceutical company based in Cambridge, Boston,…
Read More...

BONE THERAPEUTICS announces that it has signed the definitive subscription agreement for a maximum EUR 5 million convertible bonds (CBs) facility arranged by ABO Securities, through its…
Read More...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Takeda announced to transfer the marketing authorization in Japan for Moderna’s…
Read More...

NRG Therapeutics Ltd an innovative neuroscience company targeting mitochondrial dysfunction, is pleased to announce that it has received a highly competitive Biomedical Catalyst (BMC)…
Read More...

Novartis announced the US Food and Drug Administration (FDA) has granted accelerated approval for Kymriah (tisagenlecleucel) for the treatment of adult patients with relapsed or…
Read More...

Jubilant Pharmova Limited has announced that Jubilant Pharma Limited, a wholly owned subsidiary of the Company, through one of its wholly owned subsidiaries, Jubilant HollisterStier…
Read More...

Sirnaomics Ltd. a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today the launch of a Phase I clinical trial of the Company's siRNA…
Read More...

Evotec SE announced the signing of a definitive agreement under which Evotec will acquire 100% of the capital of Rigenerand Srl, a leading cell technology company, for a purchase price…
Read More...

GSK plc announced that a two-dose schedule for its HPV vaccine Cervarix  has been approved by China’s NMPA for girls aged 9 to 14. With this approval, Cervarix is the first imported…
Read More...

Eli Lilly and Company plans to expand its manufacturing footprint in Indiana by investing $2.1 billion in two new manufacturing sites at Indiana's LEAP Lebanon Innovation and Research…
Read More...

Hyundai Bioscience will go straight to the US with its broad-spectrum antiviral drug candidate to treat monkeypox. Hyundai Bioscience has decided to submit a request for a fast track…
Read More...

Servier, a leader in oncology committed to bringing the promise of tomorrow to the patients we serve, announced that the U.S. Food and Drug Administration (FDA) approved TIBSOVO …
Read More...